# Laboratory ADLB validation status — educational case study

**Disposition: internal QC and transport read-back completed; not CDISC-conformant or submission-ready by certification.**

## Completed, supported by reported local execution and previous review

- Full-visit laboratory analysis dataset: 59,580 records, 254 participants, 47 laboratory parameters.
- Ten programmed checks passed; separate internal review recorded 22 passing checks and two review flags.
- Independently loaded SDTM LB source replay: zero discrepancies reported in Step 10. This is not a full independent ADaM derivation.
- 31-column SAS XPT v5 candidate generated locally. User-reported read-back comparison showed zero differences for all 31 variables after explicit blank/NA normalization and numeric tolerance. The actual local XPT and read-back output are not included here; this publication relies on the reported console result.
- Original high-dose vs placebo Week 2 ANCOVA: +1.68 U/L (95% CI -0.65 to +4.01), p=0.1569; model N=239. Original analysis not rerun or changed for this upgrade.

## Unresolved review / release gates

1. 917 selected records without baseline (178 unique subject–parameter combinations): preserve missing BASE/CHG/PCHG; review baseline eligibility and sample timing.
2. 1,664 source records without mapped analysis visits: none selected for analysis. Review windows and unscheduled handling; 12 rows source-labeled BASELINE warrant timing adjudication.
3. Provisional treatment/safety population rules and 0/1 codes for KETONES/UROBIL need source definitions and review.
4. Draft 31-variable metadata and 47-parameter metadata require review/approval: labels, types, lengths, controlled terminology, origins, derivations and value-level metadata.
5. No approved Define-XML, externally executed version-matched conformance report, full independent raw-SDTM-to-ADaM rebuild, sponsor signoff or agency acceptance.

**Do not characterize this educational analysis as a validated regulatory submission.**

Standards references: [CDISC ADaMIG v1.3](https://www.cdisc.org/standards/foundational/adam/adamig-v1-3), [FDA Study Data Technical Conformance Guide (June 2026)](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/study-data-technical-conformance-guide-technical-specifications-document).
